Shopping Cart
- Remove All
- Your shopping cart is currently empty
Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
200 mg | $48 | In Stock | |
500 mg | $89 | In Stock | |
1 g | $119 | In Stock | |
1 mL x 10 mM (in DMSO) | $55 | In Stock |
Description | Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010. |
Alias | Ureidoglutaric acid, N-Carbamyl-L-glutamic acid, N-Carbamylglutamate, Carbamylglutamic acid, Carbamino-L-glutamic acid, Carbaglu |
Molecular Weight | 190.15 |
Formula | C6H10N2O5 |
Cas No. | 1188-38-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (236.66 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.